|
|
|
|
| LEADER |
02494nam a2200529 u 4500 |
| 001 |
EB001843149 |
| 003 |
EBX01000000000000001007138 |
| 005 |
20251007000000.0 |
| 007 |
tu||||||||||||||||||||| |
| 008 |
180730 r ||| eng |
| 020 |
|
|
|z 0833085492
|
| 020 |
|
|
|a 0833085492
|
| 020 |
|
|
|z 9780833085498
|
| 020 |
|
|
|a 9780833085498
|
| 050 |
|
4 |
|a RA395.A3
|
| 100 |
1 |
|
|a Garber, Steven
|
| 245 |
0 |
0 |
|a Redirecting innovation in U.S. health care
|h Elektronische Ressource
|b options to decrease spending and increase value
|c Steven Garber [and others]
|
| 260 |
|
|
|a Santa Monica
|b RAND Corporation
|c 2014©2014, 2014
|
| 300 |
|
|
|a xxvii, 105 pages
|b illustrations
|
| 505 |
0 |
|
|a Includes bibliographical references (pages 91-105)
|
| 505 |
0 |
|
|a Introduction -- The context for medical product innovation -- Methods -- Analysis -- Policy options to improve the U.S. medical product innovation system -- In conclusion -- Appendix A: Cost-effectiveness and value -- Appendix B: An economic model of innovation
|
| 651 |
|
4 |
|a United States / fast
|
| 653 |
|
|
|a Cost effectiveness
|
| 653 |
|
|
|a Medical innovations
|
| 653 |
|
|
|a Medical care, Cost of
|
| 653 |
|
|
|a Medical care / United States
|
| 653 |
|
|
|a Medical care
|
| 653 |
|
|
|a MEDICAL / Allied Health Services / Medical Technology
|
| 653 |
|
|
|a Biomedical engineering
|
| 653 |
|
|
|a POLITICAL SCIENCE / Public Policy / Social Security
|
| 653 |
|
|
|a Medical policy
|
| 653 |
|
|
|a POLITICAL SCIENCE / Public Policy / Social Services & Welfare
|
| 700 |
1 |
|
|a Gates, Susan M.
|
| 700 |
1 |
|
|a Keeler, Emmett B.
|
| 700 |
1 |
|
|a Vaiana, Mary E.
|
| 041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
| 989 |
|
|
|b ZDB-39-JOA
|a JSTOR Open Access Books
|
| 490 |
0 |
|
|a RAND Corporation research report series
|
| 500 |
|
|
|a "RR-308"--Page 4 of cover
|
| 024 |
8 |
|
|a RAND/RR-308
|
| 773 |
0 |
|
|t Books at JSTOR: Open Access
|
| 776 |
|
|
|z 9780833085474
|
| 776 |
|
|
|z 0833085468
|
| 776 |
|
|
|z 0833085476
|
| 856 |
4 |
0 |
|u https://www.jstor.org/stable/10.7249/j.ctt6wq8jv
|x Verlag
|3 Volltext
|
| 082 |
0 |
|
|a 362.10973
|
| 520 |
|
|
|a New medical technologies are a leading driver of U.S. health care spending. This report identifies promising policy options to change which medical technologies are created, with two related policy goals: (1) Reduce total health care spending with the smallest possible loss of health benefits, and (2) ensure that new medical products that increase spending are accompanied by health benefits that are worth the spending increases
|